Entera Bio Ltd
NASDAQ:ENTX

Watchlist Manager
Entera Bio Ltd Logo
Entera Bio Ltd
NASDAQ:ENTX
Watchlist
Price: 1.61 USD -3.59% Market Closed
Market Cap: 58.5m USD
Have any thoughts about
Entera Bio Ltd?
Write Note

Intrinsic Value

ENTX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ENTX stock under the Base Case scenario is 0.02 USD. Compared to the current market price of 1.61 USD, Entera Bio Ltd is Overvalued by 99%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ENTX Intrinsic Value
0.02 USD
Overvaluation 99%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Entera Bio Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ENTX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ENTX?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Entera Bio Ltd

Provide an overview of the primary business activities
of Entera Bio Ltd.

What unique competitive advantages
does Entera Bio Ltd hold over its rivals?

What risks and challenges
does Entera Bio Ltd face in the near future?

Has there been any significant insider trading activity
in Entera Bio Ltd recently?

Summarize the latest earnings call
of Entera Bio Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Entera Bio Ltd.

Provide P/S
for Entera Bio Ltd.

Provide P/E
for Entera Bio Ltd.

Provide P/OCF
for Entera Bio Ltd.

Provide P/FCFE
for Entera Bio Ltd.

Provide P/B
for Entera Bio Ltd.

Provide EV/S
for Entera Bio Ltd.

Provide EV/GP
for Entera Bio Ltd.

Provide EV/EBITDA
for Entera Bio Ltd.

Provide EV/EBIT
for Entera Bio Ltd.

Provide EV/OCF
for Entera Bio Ltd.

Provide EV/FCFF
for Entera Bio Ltd.

Provide EV/IC
for Entera Bio Ltd.

Show me price targets
for Entera Bio Ltd made by professional analysts.

What are the Revenue projections
for Entera Bio Ltd?

How accurate were the past Revenue estimates
for Entera Bio Ltd?

What are the Net Income projections
for Entera Bio Ltd?

How accurate were the past Net Income estimates
for Entera Bio Ltd?

What are the EPS projections
for Entera Bio Ltd?

How accurate were the past EPS estimates
for Entera Bio Ltd?

What are the EBIT projections
for Entera Bio Ltd?

How accurate were the past EBIT estimates
for Entera Bio Ltd?

Compare the revenue forecasts
for Entera Bio Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Entera Bio Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Entera Bio Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Entera Bio Ltd compared to its peers.

Compare the P/E ratios
of Entera Bio Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Entera Bio Ltd with its peers.

Analyze the financial leverage
of Entera Bio Ltd compared to its main competitors.

Show all profitability ratios
for Entera Bio Ltd.

Provide ROE
for Entera Bio Ltd.

Provide ROA
for Entera Bio Ltd.

Provide ROIC
for Entera Bio Ltd.

Provide ROCE
for Entera Bio Ltd.

Provide Gross Margin
for Entera Bio Ltd.

Provide Operating Margin
for Entera Bio Ltd.

Provide Net Margin
for Entera Bio Ltd.

Provide FCF Margin
for Entera Bio Ltd.

Show all solvency ratios
for Entera Bio Ltd.

Provide D/E Ratio
for Entera Bio Ltd.

Provide D/A Ratio
for Entera Bio Ltd.

Provide Interest Coverage Ratio
for Entera Bio Ltd.

Provide Altman Z-Score Ratio
for Entera Bio Ltd.

Provide Quick Ratio
for Entera Bio Ltd.

Provide Current Ratio
for Entera Bio Ltd.

Provide Cash Ratio
for Entera Bio Ltd.

What is the historical Revenue growth
over the last 5 years for Entera Bio Ltd?

What is the historical Net Income growth
over the last 5 years for Entera Bio Ltd?

What is the current Free Cash Flow
of Entera Bio Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Entera Bio Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Entera Bio Ltd

Current Assets 7.3m
Cash & Short-Term Investments 6.9m
Receivables 111k
Other Current Assets 314k
Non-Current Assets 401k
PP&E 381k
Other Non-Current Assets 20k
Current Liabilities 1.1m
Accounts Payable 184k
Accrued Liabilities 927k
Non-Current Liabilities 178k
Other Non-Current Liabilities 178k
Efficiency

Earnings Waterfall
Entera Bio Ltd

Revenue
99k USD
Cost of Revenue
-90k USD
Gross Profit
9k USD
Operating Expenses
-7.2m USD
Operating Income
-7.1m USD
Other Expenses
-12k USD
Net Income
-7.2m USD

Free Cash Flow Analysis
Entera Bio Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ENTX Profitability Score
Profitability Due Diligence

Entera Bio Ltd's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

17/100
Profitability
Score

Entera Bio Ltd's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

ENTX Solvency Score
Solvency Due Diligence

Entera Bio Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Entera Bio Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ENTX Price Targets Summary
Entera Bio Ltd

Wall Street analysts forecast ENTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ENTX is 10.2 USD with a low forecast of 10.1 USD and a high forecast of 10.5 USD.

Lowest
Price Target
10.1 USD
527% Upside
Average
Price Target
10.2 USD
534% Upside
Highest
Price Target
10.5 USD
552% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ENTX?

Click here to dive deeper.

Dividends

Entera Bio Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for ENTX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ENTX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Entera Bio Ltd Logo
Entera Bio Ltd

Country

Israel

Industry

Biotechnology

Market Cap

58.8m USD

Dividend Yield

0%

Description

Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of orally delivered large molecule therapeutics. The firm conducts clinical trials on its proprietary technology, which allows oral delivery of large molecules and biologics while enhancing their absorption in the gastrointestinal (GI) tract. Entera Bio Ltd's technology addresses the major problems of oral drug delivery of large molecule active pharmaceutical ingredients (APIs). Most large molecules cannot be administered orally as they are not readily absorbed by the gastrointestinal tract and are rapidly degraded by a myriad of enzymes and acids in the gastrointestinal tract. The Company’s proprietary technologies act synergistically to transport and protect large molecules. The firm develops drugs for hypoparathyroidism, osteoporosis and bone healing.

Contact

JERUSALEM
Hadassah / Jerusalem Bio, Park, 5th Floor
+97225327151.0
www.enterabio.com

IPO

2018-06-28

Employees

18

Officers

CEO & Director
Ms. Miranda J. Toledano M.B.A.
Chief Financial Officer
Ms. Dana Yaacov-Garbeli CPA
Chief Operating Officer
Dr. Hillel Galitzer M.B.A., Ph.D.
Chief of Research & Development
Dr. Gregory Burshtein Ph.D.

See Also

Discover More
What is the Intrinsic Value of one ENTX stock?

The intrinsic value of one ENTX stock under the Base Case scenario is 0.02 USD.

Is ENTX stock undervalued or overvalued?

Compared to the current market price of 1.61 USD, Entera Bio Ltd is Overvalued by 99%.

Back to Top